Short Bowel Syndrome Market Growth Rate and Opportunity Assessment till 2028

コメント · 325 ビュー

Short Bowel Syndrome Market with key details about market share, market size, market revenue growth, CAGR, and other vital statistical data for the forecast period of 2021-2028.

Reports and Data has recently added a new comprehensive research report on the global Short Bowel Syndrome Market with key details about market share, market size, market revenue growth, CAGR, and other vital statistical data for the forecast period of 2021-2028. The report is furnished with valuable insights gathered from extensive primary and secondary research and further validated from industry experts and professionals. The report segments the global based on type, application, end-use, and regions. The report leverages robust bottom-up and top-down approaches to provide crucial insights about the market including historical and forecast data. The report provides a comprehensive overview of key initiatives and strategies adopted by the key market players to increase their revenue growth and gain a robust footing in the market.

Top companies profiled in the report include:

  • Shire plc (Takeda Pharmaceutical Company Limited)
  • Zealand Pharma A/S
  • Sancilio Company, Inc.
  • OxThera
  • Nutrinia Ltd.
  • Ardelyx, Inc.
  • Emmaus Life Sciences, Inc.
  • GLyPharma Therapeutic, Inc. (Pfizer Inc.)
  • Merck KGaA
  • Naia Pharmaceuticals, Inc.
  • Hanmi Pharm.Co., Ltd.
  • Pharmascience, Inc.
  • PhaseBio Pharmaceuticals Inc.
  • AstraZeneca PLC
  • Johnson Johnson Services
  • Teva Pharmaceutical Industries Ltd

Diagnosis Outlook (Revenue, USD Billion; 2018-2028)

  • Imaging Tests
    • X-Ray
    • Computerized Tomography (CT) Scan
    • Magnetic Resonance Imaging (MRI)
    • Others
  • Blood Tests
  • Fecal Fat Tests
  • Bone Density Test
  • Stool Exam
  • Physical Exam
  • Others

Drug Type Outlook (Revenue, USD Billion; 2018-2028)

  • Glucagon-like Peptide-2 (GLP-2)
  • Glutamine,
  • Zorbtive
  • GlutaSolve
  • Teduglutide (Gattex)
  • Growth Hormone
  • Others

Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)

  • Diagnostics Centers/Multispecialty Clinics
  • Hospitals
  • Hospital Pharmacies
  • Others

Key Market Regions Covered in the Report:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4349

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

 

コメント